Pharmacist participation in medical homes aids outcomes

Pharmacist participation in medical homes aids outcomes

(HealthDay)—A program that integrates clinical pharmacists into established primary care medical home practices helps patients achieve better disease management for high blood pressure (HBP) and diabetes mellitus (DM), compared to usual care, according to a study published recently in the Journal of International Medical Research.

Kimberly D. Brunisholz, Ph.D., from Intermountain Healthcare in Salt Lake City, and colleagues retrospectively examined the effectiveness of the Intermountain Healthcare Collaborative Pharmacist Support Services (CPSS) program (2012 to 2015) among 359 diagnosed with DM and/or HBP. Patients were propensity-matched to a reference cohort of 999 participants.

The researchers found that, compared with the reference group, CPSS patients were 93 percent more likely to achieve a blood pressure goal <140/90 mm Hg, 57 percent more likely to achieve hemoglobin A1c values <8 percent, and 87 percent more likely to achieve both disease management goals. Across the entire study period, time-to-goal achievement showed increased separation between the study cohorts (P < 0.001), particularly at 180 days post-intervention (HBP: P < 0.001; DM: P < 0.05).

"CPSS participation is associated with significant improvement in achievement of disease management goals, time to achievement, and increased ambulatory encounters compared with the matched no-CPSS cohort," the authors write.

More information: Abstract/Full Text

Copyright © 2017 HealthDay. All rights reserved.

Citation: Pharmacist participation in medical homes aids outcomes (2017, December 15) retrieved 25 April 2024 from https://medicalxpress.com/news/2017-12-pharmacist-medical-homes-aids-outcomes.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Reduction in common heart hormone associated with improved outcomes and lower mortality

4 shares

Feedback to editors